69久久99精品久久久久久婷婷,女人和男人哪个更好色 ,亚洲国产欧美日韩综合另类久久

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專(zhuān)享價(jià)	數(shù)量
暫無(wú)牌價(jià)信息，您可以發(fā)送詢(xún)價(jià)，我們會(huì)盡快給你回復(fù)。

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專(zhuān)享價(jià)

數(shù)量

暫無(wú)牌價(jià)信息，您可以發(fā)送詢(xún)價(jià)，我們會(huì)盡快給你回復(fù)。

基本信息

英文名稱(chēng)	Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
中文名稱(chēng)	法瑞西單抗
CAS號(hào)	1607793-29-2
儲(chǔ)存條件	store at -20°C

產(chǎn)品詳情

Faricimab is a pioneering humanized bispecific antibody that targets both VEGF-A and Ang-2, offering a dual inhibition approach for retinal diseases like DME and nAMD. By inhibiting VEGF-A, it reduces endothelial cell proliferation and vascular permeability, while blocking Ang-2 is believed to enhance vascular stability and counteract VEGF-A effects. Faricimab has demonstrated a significant reduction in annual injections compared to other anti-VEGF treatments, with a comparable efficacy and safety profile, positioning it as a valuable treatment option for patients with retinal diseases.

相關(guān)文獻(xiàn)

Review of real-world evidence of dual inhibition of VEGF-A and ANG-2 with faricimab in NAMD and DME[J].

PMID: 38233896 PMCID: PMC10795384 DOI: 10.1186/s40942-024-00525-9

PMID: 37936232 PMCID: PMC10631190 DOI: 10.1186/s40942-023-00507-3

PMID: 37377777 PMCID: PMC10291265 DOI: 10.3389/fncel.2023.1192464

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒(méi)有相關(guān)產(chǎn)品

瀏覽記錄

黄片一区二区三区在线观看-亚洲av综合久久国产激情按摩店-欧美日韩国产长车超污-欧美日韩偷拍精品视频

法瑞西單抗

Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)

化學(xué)品安全說(shuō)明書(shū)(MSDS)